Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis From Healthy Blood Donors and Patients With Latent or Active Tuberculosis.

NCT06580639 is registered in ClinicalTrials.gov with Linkoeping University as lead sponsor.

NCT NCT06580639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06580639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis From Healthy Blood Donors and Patients With Latent or Active Tuberculosis.
Lead sponsor
Linkoeping University
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2020
Completion date
December 1, 2025
Enrollment
280 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunologic activity alteration, tuberculosis